Endocyte
Endocyte is a biopharmaceutical company and leader in developing targeted therapies for the personalized treatment of cancer. The company's drug conjugation technology targets therapeutics and companion imaging agents specifically to the site of diseased cells. Endocyte's lead program is a prostate specific membrane antigen (PSMA)-targeted radioligand therapy, 177Lu-PSMA-617, entering phase 3 for metastatic castration resistant prostate cancer (mCRPC). Endocyte is also advancing its adaptor-controlled CAR T-cell therapy into the clinic, where it will be studied in osteosarcoma.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
14
51 to 200 range
Open roles
—
no listings
Distinct roles
9
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 9 verified contacts at Endocyte
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- DT
Derek Tucker
Staff Accountant · Finance & Accounting
EmailPhone - PK
Patrick Klein
Director of Toxicology · Science
EmailPhone - BB
Beverly Bailey
Administrative Assistant · General Business & Management
EmailPhone - ML
Mary Lagunes
Receiving Lab Assistant · Other
EmailPhone - PB
Peggy Beck
Senior Analytical Chemist · Science
EmailPhone
Showing 5 of 9 verified contacts
Top roles at Endocyte
9 distinct titles indexed · top 9 shown.
- 1administrative assistant
- 1consultant
- 1director of toxicology
- 1mastercontrol consultant
- 1receiving lab assistant
- 1research associate
- 1research scientist
- 1senior analytical chemist
- 1staff accountant
Sign up to unlock all 9 contacts at Endocyte
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Endocyte
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.